Red-shifted optogenetics comes to the spotlight
Clin Transl Med
.
2022 Apr;12(4):e807.
doi: 10.1002/ctm2.807.
Authors
Tianlu Wang
1
,
Siyao Liu
1
,
Yun Huang
2
3
,
Yubin Zhou
1
3
Affiliations
1
Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, Texas, USA.
2
Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, Texas, USA.
3
Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, Texas, USA.
PMID:
35389568
PMCID:
PMC8989019
DOI:
10.1002/ctm2.807
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
Light*
Optogenetics*
Grants and funding
R01 HL134780/HL/NHLBI NIH HHS/United States
R01 CA232017/CA/NCI NIH HHS/United States